Treatment Strategies and Survival Outcomes in Breast Cancer
| Treatment Strategies and Survival Outcomes in Breast Cancer |
| Autore | Cheung Kwok-Leung |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (264 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
abemaciclib
advanced breast cancer anthracycline resistance antihormone therapy APOBEC3B aromatase inhibitors ATM basal-like breast cancer biomarker BRCA breast cancer Breast Cancer breast cancer survivors breast-conserving therapy cancer treatment cell-free DNA CHEK2 chemotherapy circulating tumor cells cMet colorectal cancer comparative effectiveness contralateral breast cancer contralateral prophylactic mastectomy cyclin E disease-free survival ductal carcinoma in situ Endocrine therapy ERCC1 exercise characteristics family history fulvestrant gene expression geriatric oncology HDAC5 inhibitors HER2 c-erbB2 HER2/neu histone deacetylase incidence infiltrating breast cancer invasive breast cancer lactate dehydrogenase lapatinib LDH liquid biopsy LKB1 LMK-235 lymph-node ratio mammography screening mastectomy metastatic metastatic breast cancer Metformin monitoring metastatic breast cancer mutation carriers n/a NCDB next-generation sequencing older patients Older women outcome overdiagnosis PALB2 palbociclib pertuzumab physical activity physical function PIK3CA prognosis radiotherapy relative survival ribociclib SEER serum biomarker social well-being Src kinase stage IV survival T-DM1 taxane sensitivity trastuzumab tumor biology young women zero-inflated Poisson regression model |
| ISBN | 3-03928-759-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910404084403321 |
Cheung Kwok-Leung
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urological Cancer 2021
| Urological Cancer 2021 |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (328 p.) |
| Soggetto topico |
Chemistry
Research & information: general |
| Soggetto non controllato |
177Lu-PSMA
abiraterone ablation margins advanced urothelial carcinoma AHNAK2 autopsy Bacillus Calmette-Guérin (BCG) biomarker biomarkers biopsy bladder cancer bladder cancer cell lines bladder carcinoma cancer cell migration comparative effectiveness comparative oncology ctDNA decision making diagnosis divergent differentiation docetaxel dog enzalutamide epiplakin epithelial-mesenchymal transition fluorescence confocal microscopy focal therapy frail patients frailty FTY-720 game theory genomic analysis genomic signatures glutaminase Hounsfield units image-guided immune checkpoint inhibitor immune checkpoint inhibitors immunohistochemistry immunotherapy in situ methods inflammation inflammatory indices latent cancer liquid biopsy machine learning magnetic resonance imaging mCRPC metastasectomy metastasis metastatic prostate cancer microenvironment molecular subtypes mortality n/a novel hormonal therapies OIP5 oncological outcomes papillary renal cell carcinoma PD-1 PD-L1 PLK1 positron-emission tomography postoperative complications preclinical studies prediction model preneoplastic lesion prognosis prognostic prognostic factor prognostic index prostate prostate biopsy prostate cancer prostatic atrophy prostatic neoplasms PSA PSMA-RLT psoas muscle radical cystectomy radiosensitisation radiotherapy real-world treatment pattern renal cell carcinoma screening trial sphingosine 1-phosphate receptor 1 stereotactic body radiotherapy survival therapy TRIPOD tumor ecology tumor thrombus tumorigenesis tumour mutational board ultrasonography urinary bladder neoplasms urine urothelial carcinoma variant morphology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576872803321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||